Knowledge Center

Patent / Aug 04, 2022

Inhaled ivermectin

Authors:
  • Beatriz Fernandes
  • João Henriques
  • Eunice Costa
  • Venkatesh Naini
Source:
US 20220241307

The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý

Also in the Knowledge Center

Related Content

Regulatory Affairs

ËÄÉ«AV has filings with every world health authority that has a DMF system for APIs including FDA EDQM PMDA,MHRA, HPRA, Infarmed among others.

Page
Read more

Development by Design

Development by Design is ËÄÉ«AV’s proven spray-dried dispersion scale-up and tech-transfer methodology.

Page
Read more

The ËÄÉ«AV Experience - Lisbon

Welcome to Lisbon! Part of The ËÄÉ«AV Experience is ensuring your trip is unforgettable. Explore our suggestions for iconic attractions, exquisite cuisine, and get ready to feel the magic of this vibrant city.

Page
Read more